9.30Open10.35Pre Close3 Volume257 Open Interest102.00Strike Price2.75KTurnover156.49%IV2.13%PremiumDec 13, 2024Expiry Date6.61Intrinsic Value100Multiplier1DDays to Expiry2.31Extrinsic Value100Contract SizeAmericanOptions Type0.8203Delta0.0338Gamma14.68Leverage Ratio-1.3545Theta0.0017Rho12.04Eff Leverage0.0130Vega
Novo-Nordisk A/S Stock Discussion
FLOW trial evaluated the risk reduction associated with treatment with Ozempic ® in chronic kidney disease-related events in adults with type 2 diabetes and chronic kidney disease (CKD). FLOW, semag...
The agreement The acquisition of the three production sites was announced on February 5. On May 29, Catalent shareholders voted in favor of the pending transac...
$Novo-Nordisk A/S (NVO.US)$
new
for some reason the profile says its lly
it's so greeen
Add...
No comment yet